Clinical Trial Intelligence for Biotech and Pharma Teams
Analyze trial landscapes, protocol patterns, endpoints, enrollment signals, sponsor behavior, recent registry changes, and historical AACT structure.
Decision questions
What this solution is built to answer.
What trial designs, endpoints, comparators, and enrollment patterns define this field?
Which sponsors are moving recently, and what changed in the registry?
Where are the enrollment, geography, eligibility, or endpoint risks?
How does trial activity alter competitive, valuation, or indication strategy?
Science and method
What can change the model or gate.
ClinicalTrials.gov API research for live registry questions.
AACT SQL patterns for historical trial, sponsor, endpoint, and enrollment analysis.
Clinical trial pattern workflows for design comparison.
Recent change monitoring and scheduled background checks.
Downstream connection to valuation, competitive intelligence, and indication-expansion workflows.
Method and decision gates
How the case is computed and reviewed.
| Workflow | Role | Artifacts |
|---|---|---|
| clinical-trials-research | Trial landscape and recent activity mapping | Trial evidence tables, sponsor maps, recent update notes |
| clinical-trial-patterns | Trial design pattern analysis | Endpoint, comparator, eligibility, enrollment, and design summaries |
| clinicaltrials-api-patterns | Live ClinicalTrials.gov API execution | Registry pulls, change summaries, structured trial outputs |
Evidence inputs
Supporting evidence, rights and decision inputs.
Decision record
What remains available for review.
Deliverables
Trial landscape table with sponsor, status, phase, enrollment, endpoint, and geography fields.
Protocol-pattern brief for clinical strategy or diligence.
Recent registry-change memo with implications.
Structured inputs for valuation, CI, or indication expansion.
Proof points
Clinical trial work can route to live registry lookup or historical database analysis depending on recency and query shape.
AACT-specific patterns preserve the meaning of trial fields instead of relying on generic database guesses.
Trial outputs can feed valuation probability, competitive timing, and portfolio decisions.
Limits and review conditions
What this result does not establish.
Public registries can be incomplete or delayed. Trial intelligence must preserve the retrieval date and unresolved fields.
FAQ
Common evaluation questions.
When should ARiDA use ClinicalTrials.gov API versus AACT?
Use the API for very recent registry state and change-sensitive work. Use AACT for historical, relational, and larger structured trial analysis.
Can trial evidence feed other workflows?
Yes. Trial evidence can feed competitive landscapes, valuation probabilities, regulatory briefs, and indication-expansion scoring.
Related solutions
Competitive Intelligence
Build competitive landscapes, TPP comparisons, patent-cliff views, market-share scenarios, and response plans from live web, trial, patent, literature, and database evidence.
Biotech Valuation
Connect scientific evidence and uncertainty to PoS, rNPV, option value and the asset or portfolio decision under review.
Indication Expansion
Scan, assess, and sequence indication opportunities with scientific rationale, clinical feasibility, competitive density, IP context, market structure, and valuation logic.
Related reading
Monitor clinical trial changes without confusing updates with events
Preserve registry timestamps, field-level differences and materiality rules before escalating a signal.
Combine scientific data and code without erasing provenance
Acquisition, normalization and computation need separate records inside the same decision case.
Run a competitive landscape around a decision, not a company list
A useful landscape explains which competitor changes the target profile, timing or investment case.